Jim Schutz
Oculus Chief Operating Officer
As you may have recently read, we received a clearance from the FDA for our new Microcyn Dermatology HydroGel product, our first dermatology product and a terrific new opportunity for the team at Oculus.
We’ve been quizzed repeatedly the last several days for the “story” behind the new product and our push into dermatology. Bear with me for a peek behind the scenes.